MedPath

OYAVAS 25 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION

OYAVAS 25 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION

Commercialized
Register Number

1201510001

Prescription Type

Uso Hospitalario

Authorization Date

Apr 7, 2021

Dosage Form

CONCENTRADO PARA SOLUCIÓN PARA PERFUSIÓN

Route: VÍA INTRAVENOSA

Product Details

Detailed information about this CIMA AEMPS approved pharmaceutical product.

Basic Information

Key regulatory and product classification details

Regulatory Details

Register Number1201510001
EMA Approved
Yes

Drug Classification

Generic
No
Orphan
No
Biosimilar
Yes
Commercialized
Yes
CIMA AEMPS Classification

INGREDIENTS (1)

BEVACIZUMABActive
Quantity: 25 mg
Name: BEVACIZUMAB

ATC CLASSIFICATION (3)

L01F
L01FG
L01FG01

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.